To be eligible for these payouts, investors must be mindful of the ex-dividend date, which is the day the share price adjusts ...

Indian stock markets on Thursday failed to hold on to their early gains and ended flat in a volatile session, weighed down by ...

The Indian Stock Markets on Thursday failed to hold on to their early gains and ended flat in a volatile session. Indices were weighed down by weak global cues and profit booking.

Astral, Divis, Eicher drove Marcellus CCP gains. Marcellus CCP shifted from large-cap consumption. New focus: healthcare, ...

Divis Laboratories Ltd is quoting at Rs 7296, up 1.5% on the day as on 12:44 IST on the NSE. The stock is up 6.81% in last one year as compared to a 4.17% fall in NIFTY and a 15.39% fall in the Nifty ...

Brokerages expressed caution on frontline IT stocks following June quarter earnings. Citi downgraded HCL Technologies to Sell ...

Axis Direct said that SBI Cards confirmed a short-term trend reversal on the daily charts by forming a double bottom ...

Maintain Reduce; Cut TP to Rs 3350 from Rs 3450 Decent performance amid demand uncertainties Sequential growth and margin expansion through FY27 Factor in higher forex losses due to long-term hedges.

As the largest pure-play API/CDMO, Divi's should continue benefiting from custom-synthesis order-book conversion and the ...

Welcome to the Divis Labs Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a ...

Investor interest in Divis Laboratories continues to be robust on the back of growing demand for Indian CDMO (contract development and manufacturing outsourcing) services. In July 2024, we recommended ...

Synopsis: Divi’s Laboratories is in focus after reporting Q4 growth, with a 9.5% rise in profit and a 13.4% increase in revenue YoY, along with a ₹30 dividend. However, brokerages are split. Citi and ...